New cellular therapy offers hope for multiple myeloma patients

UChicago Medicine is the first program in Chicago to offer Abecma, a cell-based gene therapy for patients with treatment-resistant multiple myeloma.

Cancer and COVID-19: the impact of missed screenings in vulnerable communities
Novel biomarker predicts how non-small cell lung cancer will progress after immunotherapy